Literature DB >> 31730862

Stromal reprogramming: A target for tumor therapy.

Masoud Najafi1, Keywan Mortezaee2, Jamal Majidpoor3.   

Abstract

Cancer associated fibroblasts (CAFs) as the dominant, long-lived and highly plastic cells within the tumor microenvironment (TME) with multi-faceted roles that are endowed with tumor aggressive features. They can instruct and shape the stroma of tumor into being a highly qualified bed for cellular recruitment, differentiation and plasticity in the host tissue or secondary organ/s. In this Review, we have a discussion over CAF reprogramming as a general concept, inducers and outcomes, pursued by suggesting potential strategies to combat this key promoter of tumor.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer associated fibroblasts (CAFs); Cancer cell; Extracellular matrix (ECM); Metabolic; Reprogramming; Transforming growth factor (TGF); Tumor microenvironment (TME)

Mesh:

Substances:

Year:  2019        PMID: 31730862     DOI: 10.1016/j.lfs.2019.117049

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  21 in total

Review 1.  Steps in metastasis: an updated review.

Authors:  Jamal Majidpoor; Keywan Mortezaee
Journal:  Med Oncol       Date:  2021-01-04       Impact factor: 3.064

Review 2.  NK and cells with NK-like activities in cancer immunotherapy-clinical perspectives.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Med Oncol       Date:  2022-06-18       Impact factor: 3.064

Review 3.  Key promoters of tumor hallmarks.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Int J Clin Oncol       Date:  2021-11-13       Impact factor: 3.402

Review 4.  Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated.

Authors:  Keywan Mortezaee; Jamal Majidpoor; Ebrahim Kharazinejad
Journal:  Med Oncol       Date:  2022-09-07       Impact factor: 3.738

Review 5.  Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Cell Oncol (Dordr)       Date:  2022-05-19       Impact factor: 7.051

Review 6.  Tumour invasion and dissemination.

Authors:  Ryan Lusby; Philip Dunne; Vijay K Tiwari
Journal:  Biochem Soc Trans       Date:  2022-06-30       Impact factor: 4.919

Review 7.  Current Advances in PD-1/PD-L1 Blockade in Recurrent Epithelial Ovarian Cancer.

Authors:  Yuedi Zhang; Qiulin Cui; Manman Xu; Duo Liu; Shuzhong Yao; Ming Chen
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

8.  Transitional cell carcinoma matrix stiffness regulates the osteopontin and YAP expression in recurrent patients.

Authors:  Hadi Ghasemi; Seyed Habibollah Mousavibahar; Mohammad Hashemnia; Jamshid Karimi; Iraj Khodadadi; Heidar Tavilani
Journal:  Mol Biol Rep       Date:  2021-06-04       Impact factor: 2.316

Review 9.  Addressing activation of WNT beta-catenin pathway in diverse landscape of endometrial carcinogenesis.

Authors:  Pradip De; Jennifer Carlson Aske; Adam Dale; Luis Rojas Espaillat; David Starks; Nandini Dey
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 10.  Targeting of cancer cell death mechanisms by resveratrol: a review.

Authors:  Xiao Fu; Mu Li; Cuilian Tang; Zezhi Huang; Masoud Najafi
Journal:  Apoptosis       Date:  2021-09-25       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.